Tuberculosis. The Board of Health may submit claims on a case-by-case basis for second-line and select adjunct medications related to the treatment of active tuberculosis and latent tuberculosis infection. For more information on the reimbursement process, see section 9 of the Tuberculosis Program Guideline, 2018 (or as current).
Appears in 3 contracts
Sources: Public Health Funding and Accountability Agreement, Public Health Funding Agreement, Public Health Funding Agreement